ASAPF
Price
$0.22
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
16.64M
NNCSF
Price
$2.50
Change
-$0.30 (-10.71%)
Updated
Sep 25 closing price
Capitalization
825.33M
Interact to see
Advertisement

ASAPF vs NNCSF

Header iconASAPF vs NNCSF Comparison
Open Charts ASAPF vs NNCSFBanner chart's image
Aurora Spine
Price$0.22
Change-$0.00 (-0.00%)
Volume$10K
Capitalization16.64M
Nanosonics
Price$2.50
Change-$0.30 (-10.71%)
Volume$1.2K
Capitalization825.33M
ASAPF vs NNCSF Comparison Chart in %
Loading...
ASAPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASAPF vs. NNCSF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASAPF is a StrongBuy and NNCSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ASAPF: $0.22 vs. NNCSF: $2.50)
Brand notoriety: ASAPF and NNCSF are both not notable
ASAPF represents the Medical/Nursing Services, while NNCSF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ASAPF: 21% vs. NNCSF: 77%
Market capitalization -- ASAPF: $16.64M vs. NNCSF: $825.33M
ASAPF [@Medical/Nursing Services] is valued at $16.64M. NNCSF’s [@Pharmaceuticals: Other] market capitalization is $825.33M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.02B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.49B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASAPF’s FA Score shows that 0 FA rating(s) are green whileNNCSF’s FA Score has 0 green FA rating(s).

  • ASAPF’s FA Score: 0 green, 5 red.
  • NNCSF’s FA Score: 0 green, 5 red.
According to our system of comparison, ASAPF is a better buy in the long-term than NNCSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASAPF’s TA Score shows that 5 TA indicator(s) are bullish while NNCSF’s TA Score has 2 bullish TA indicator(s).

  • ASAPF’s TA Score: 5 bullish, 4 bearish.
  • NNCSF’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ASAPF is a better buy in the short-term than NNCSF.

Price Growth

ASAPF (@Medical/Nursing Services) experienced а +0.81% price change this week, while NNCSF (@Pharmaceuticals: Other) price change was -7.41% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +9.32%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.51%. For the same industry, the average monthly price growth was -3.36%, and the average quarterly price growth was +8.17%.

Industries' Descriptions

@Medical/Nursing Services (-2.15% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-2.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NNCSF($825M) has a higher market cap than ASAPF($16.6M). NNCSF YTD gains are higher at: 19.048 vs. ASAPF (-20.867). NNCSF has higher annual earnings (EBITDA): 31.8M vs. ASAPF (88.7K). NNCSF has more cash in the bank: 161M vs. ASAPF (581K). ASAPF has less debt than NNCSF: ASAPF (3.63M) vs NNCSF (7.69M). NNCSF has higher revenues than ASAPF: NNCSF (199M) vs ASAPF (18.4M).
ASAPFNNCSFASAPF / NNCSF
Capitalization16.6M825M2%
EBITDA88.7K31.8M0%
Gain YTD-20.86719.048-110%
P/E RatioN/A56.64-
Revenue18.4M199M9%
Total Cash581K161M0%
Total Debt3.63M7.69M47%
FUNDAMENTALS RATINGS
ASAPF vs NNCSF: Fundamental Ratings
ASAPF
NNCSF
OUTLOOK RATING
1..100
1630
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
98
Overvalued
PROFIT vs RISK RATING
1..100
94100
SMR RATING
1..100
9668
PRICE GROWTH RATING
1..100
5645
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASAPF's Valuation (34) in the null industry is somewhat better than the same rating for NNCSF (98). This means that ASAPF’s stock grew somewhat faster than NNCSF’s over the last 12 months.

ASAPF's Profit vs Risk Rating (94) in the null industry is in the same range as NNCSF (100). This means that ASAPF’s stock grew similarly to NNCSF’s over the last 12 months.

NNCSF's SMR Rating (68) in the null industry is in the same range as ASAPF (96). This means that NNCSF’s stock grew similarly to ASAPF’s over the last 12 months.

NNCSF's Price Growth Rating (45) in the null industry is in the same range as ASAPF (56). This means that NNCSF’s stock grew similarly to ASAPF’s over the last 12 months.

NNCSF's P/E Growth Rating (88) in the null industry is in the same range as ASAPF (100). This means that NNCSF’s stock grew similarly to ASAPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASAPFNNCSF
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
44%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
58%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
46%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
43%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 19 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
63%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
ASAPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNCSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FTAEX14.36N/A
N/A
Fidelity Advisor Total Intl Equity A
SSCYX6.31N/A
N/A
Saratoga Small Capitalization A
LMCLX9.14N/A
N/A
Miller Income I
USNQX60.44N/A
N/A
Victory NASDAQ-100 Index
CFJAX35.48N/A
N/A
Calvert US Large Cap Value Rspnb Idx A

ASAPF and

Correlation & Price change

A.I.dvisor tells us that ASAPF and EMITF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASAPF and EMITF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASAPF
1D Price
Change %
ASAPF100%
-1.88%
EMITF - ASAPF
24%
Poorly correlated
N/A
PHG - ASAPF
23%
Poorly correlated
-3.07%
EDTXF - ASAPF
22%
Poorly correlated
N/A
NNCSF - ASAPF
21%
Poorly correlated
-10.71%
MASS - ASAPF
10%
Poorly correlated
+8.73%
More

NNCSF and

Correlation & Price change

A.I.dvisor tells us that NNCSF and ASAPF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NNCSF and ASAPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNCSF
1D Price
Change %
NNCSF100%
-10.71%
ASAPF - NNCSF
21%
Poorly correlated
-1.88%
NHNKY - NNCSF
8%
Poorly correlated
+1.48%
NHNKF - NNCSF
0%
Poorly correlated
N/A
NVYTF - NNCSF
0%
Poorly correlated
N/A
MRCHF - NNCSF
0%
Poorly correlated
+9.66%
More